APA

Hahn M., Böttcher S., Dietrich S., Hegenbart U., Rieger M., Stadtherr P., Bondong A., Schulz R., Ritgen M., Schmitt T., Tran T. H., Görner M., Herth I., Luft T., Schönland S., Witzens-Harig M., Zenz T., Kneba M., Ho A. D. & Dreger P. (20160819). Allogeneic hematopoietic stem cell transplantation for poor-risk CLL: dissecting immune-modulating strategies for disease eradication and treatment of relapse. : Bone marrow transplantation.

Chicago

Hahn M, Böttcher S, Dietrich S, Hegenbart U, Rieger M, Stadtherr P, Bondong A, Schulz R, Ritgen M, Schmitt T, Tran T H, Görner M, Herth I, Luft T, Schönland S, Witzens-Harig M, Zenz T, Kneba M, Ho A D and Dreger P. 20160819. Allogeneic hematopoietic stem cell transplantation for poor-risk CLL: dissecting immune-modulating strategies for disease eradication and treatment of relapse. : Bone marrow transplantation.

Harvard

Hahn M., Böttcher S., Dietrich S., Hegenbart U., Rieger M., Stadtherr P., Bondong A., Schulz R., Ritgen M., Schmitt T., Tran T. H., Görner M., Herth I., Luft T., Schönland S., Witzens-Harig M., Zenz T., Kneba M., Ho A. D. and Dreger P. (20160819). Allogeneic hematopoietic stem cell transplantation for poor-risk CLL: dissecting immune-modulating strategies for disease eradication and treatment of relapse. : Bone marrow transplantation.

MLA

Hahn M, Böttcher S, Dietrich S, Hegenbart U, Rieger M, Stadtherr P, Bondong A, Schulz R, Ritgen M, Schmitt T, Tran T H, Görner M, Herth I, Luft T, Schönland S, Witzens-Harig M, Zenz T, Kneba M, Ho A D and Dreger P. Allogeneic hematopoietic stem cell transplantation for poor-risk CLL: dissecting immune-modulating strategies for disease eradication and treatment of relapse. : Bone marrow transplantation. 20160819.